Trial of Family Focused Grief Therapy in Palliative Care and Bereavement

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborators:
Beth Israel Medical Center
Calvary Hospital, Bronx, NY
Monash University
Information provided by (Responsible Party):
Memorial Sloan-Kettering Cancer Center
ClinicalTrials.gov Identifier:
NCT00580515
First received: December 20, 2007
Last updated: August 23, 2012
Last verified: August 2012

December 20, 2007
August 23, 2012
November 2005
December 2012   (final data collection date for primary outcome measure)
Evaluate the efficacy and dose responsiveness of family intervention in preventing bereavement and depression compared with standard palliative care among family members and to examine whether distress moderates impact of FFGT [ Time Frame: 5 years ] [ Designated as safety issue: No ]
Same as current
Complete list of historical versions of study NCT00580515 on ClinicalTrials.gov Archive Site
Evaluate whether family coping and communication mediate the impact of FFGT and examine costs of FFGT and standard palliative care, and whether the additional costs are offset by reductions in community health utilization [ Time Frame: 5 years ] [ Designated as safety issue: No ]
Same as current
Not Provided
Not Provided
 
Trial of Family Focused Grief Therapy in Palliative Care and Bereavement
Randomized Controlled Trial of Family Focused Grief Therapy in Palliative Care and Bereavement

The purpose of this study is to learn how well family therapy works if given while a family member is being treated for a serious illness and whether it helps their family to continue meeting for a time after their death. The therapy aims to assist the family communication and support during both palliative care and bereavement. The investigators also want to learn how many family therapy sessions spread out over time are best for helping patients and their families.

Patients are randomly assigned to one of three groups: patients who receive standard palliative care, patients and their families who take part in 6 sessions, and patients and their families who take part in 10 sessions.

This Randomized Controlled Trial (RCT) seeks to test the efficacy and dose responsiveness of a manualized family therapy intervention called Family Focused Grief Therapy (FFGT), which is delivered to families of patients with advanced disease and continued into bereavement. Randomization is to three arms: 6 sessions of FFGT, 10 sessions of FFGT, or standard care. The study also explores the potential mediators of effective outcome, empowering further refinement of the intervention, and undertakes an analysis of health-related costs of bereavement care. It is a multi-site study involving Memorial Hospital for Cancer and Allied Diseases (a comprehensive cancer center), Calvary Hospital (a dedicated palliative care hospital with home hospice care program)and Beth Israel (a medical center with a dedicated pain and palliative care department. Consenting families will be assessed at baseline through completion of questionnaires that appraise each individual's psychosocial well-being and perception of their family's functioning. Therapy will be delivered by family therapists (social workers, psychologists, and psychiatrists), who will attend regular supervision sessions to sustain fidelity of the model of intervention. Follow-up of family members for psychosocial well-being, perceptions of family functioning, and costs of heath-related care will occur at 3, 6, 9, & 13 months after the patient's death or completion of therapy sessions.

Interventional
Not Provided
Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Supportive Care
Cancer
  • Behavioral: Family Focused Group Therapy
    6 Sessions of Family Focused Group Therapy (FFGT). The FFGT intervention will have assessment, focused therapy, consolidation, and termination phases. The first two sessions are assessment sessions and occur one week apart. There will be two or six focused intervention sessions depending on the predetermined length of therapy. The first focused intervention session is approximately two weeks after the last assessment session. Subsequent focused intervention sessions are expected to follow once every month. Finally, there will be two consolidation/termination sessions, which will occur one time each, approximately two months apart. The six session program is expected to extend over a period of 6 months and the 10 session program over 10 months.
    Other Name: FFGT
  • Behavioral: Family Focused Group Therapy
    10 Sessions of Family Focused Group Therapy (FFGT). The FFGT intervention will have assessment, focused therapy, consolidation, and termination phases. The first two sessions are assessment sessions and occur one week apart. There will be two or six focused intervention sessions depending on the predetermined length of therapy. The first focused intervention session is approximately two weeks after the last assessment session. Subsequent focused intervention sessions are expected to follow once every month. Finally, there will be two consolidation/termination sessions, which will occur one time each, approximately two months apart. The six session program is expected to extend over a period of 6 months and the 10 session program over 10 months
    Other Name: FFGT
  • Behavioral: Standard of Care
    Standard of Care Families assigned to the Usual Care Condition will receive standard psychosocial care which is based on the following patterns: Social work consultations are routinely provided to the cancer patients, but relatives are only seen during admissions or upon request.
  • Experimental: 1
    6 sessions of Family Focused Group Therapy
    Interventions:
    • Behavioral: Family Focused Group Therapy
    • Behavioral: Family Focused Group Therapy
  • Experimental: 2
    10 Sessions of Family Focused Group Therapy
    Interventions:
    • Behavioral: Family Focused Group Therapy
    • Behavioral: Family Focused Group Therapy
  • Active Comparator: 3
    Standard Care- Social work consultations are routinely provided to the cancer patients, but relatives are only seen during admissions or upon request
    Intervention: Behavioral: Standard of Care
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Active, not recruiting
700
December 2012
December 2012   (final data collection date for primary outcome measure)

Inclusion Criteria:

Subject/Patient Inclusion Criteria

  • Individuals with advanced disease/Stage 4-IV cancer who may be involved in palliative care treatment program.
  • Individuals with a poor prognosis Patient and Family Member Inclusion Criteria.
  • Per investigator's judgment participants must have satisfactory cognitive functioning to provide valid informed consent and participate in family therapy.
  • In the event that the index family member is declining or too frail to take part in family meetings, the family is able to participate without the index patient being involved in the study.
  • For every enrolled family there must be at least 2 family members willing/able to take part at the time of recruitment.
  • The presence of FRI screening scores of ≤ 9 or cohesiveness subscale score < 4 based on the perception of any single family member, including the patient.

Exclusion Criteria:

  • Inability through language to complete the study questionnaires - inability to speak English with an English-speaking therapist.
  • Age less than 12 years old for a child.
  • Patient and family member determined geographical inaccessibility to attend family sessions.
  • Significant psychiatric disturbance sufficient, in the investigator's judgment, to preclude participation in a psychotherapeutic intervention.
Both
12 Years and older
Yes
Contact information is only displayed when the study is recruiting subjects
United States
 
NCT00580515
05-120, CA115329
Not Provided
Memorial Sloan-Kettering Cancer Center
Memorial Sloan-Kettering Cancer Center
  • National Cancer Institute (NCI)
  • Beth Israel Medical Center
  • Calvary Hospital, Bronx, NY
  • Monash University
Principal Investigator: Talia Zaider, PhD Memorial Sloan-Kettering Cancer Center
Memorial Sloan-Kettering Cancer Center
August 2012

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP